title: Use of 131 I-MIBG therapy in MIBG-positive metastatic medullary thyroid carcinoma.
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Maiza
authors.forename: Solange
authors.initials: S
authors.lastname: Grunenwald
authors.forename: Philippe
authors.initials: P
authors.lastname: Otal
authors.forename: Delphine
authors.initials: D
authors.lastname: Vezzosi
authors.forename: Antoine
authors.initials: A
authors.lastname: Bennet
authors.forename: Philippe
authors.initials: P
authors.lastname: Caron
mesh_terms: D019797:3-Iodobenzylguanidine / Q000627:therapeutic use*; D000328:Adult; D018278:Carcinoma, Neuroendocrine; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy* / Q000556:secondary*; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000532:radiotherapy* / Q000556:secondary* / Q000601:surgery; D013965:Thyroidectomy; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D007457:Iodine Radioisotopes; D019797:3-Iodobenzylguanidine